Since of Jeff's personal experience with this medical innovation, he thinks it can alter the world: "it's an unbelievable new jeff brown investor trend in medicine driven by innovation that found cancer. And provided me a fighting chance to beat it very early prior to it grew into a possibly deadly problem." Jeff does not just suggest investing in this business to profit from this trend.
: "But there's more to this innovation than just saving my life. By subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff believes it will change the world of medication.
Jeff Brown uses Mirati Therapeutics as an example, which rose 8,481% in under two years. Other gains featured on The Near Future Report's sales page include: Jeff Brown is cautious to explain that past profits do not guarantee future results.
He does not advise allocating a substantial part of your portfolio to these stocks. However, Jeff also declares he has actually "gone to providers and done his own research on future revenues" to verify his suggestions. Based on that analysis, Jeff is confident that a few of his biotech stock picks will rise considerably in the near future.
2 Trillion Market that Could Save Millions of Lives? Jeff, like many financiers, believes biotech will be among the hottest tech trends over the coming years. The biotechnology market was sitting at $447. 92 billion in 2019. It's expected to grow to $833. 34 billion by 2027. Biotech is clear.
Jeff Extra resources discusses precision medicine as one example: "the biotech market is anticipated to grow 86% over the next few years. That is excellent. But listen to this, The precision medication market is expected to grow 152% during that same time" Precision medication is an emerging location of biotech that utilizes accurate biological information to compute disease danger.